About
Pricing
FAQs
Providers
Trials
Blog
Login
Get started
Finding studies
Search
Narrow
Order
Status
Recruiting
Not yet recruiting
Active, not recruiting
Enrolling by invitation
Completed
Terminated
Phase
Early phase 1
Phase 1
Phase 1–2
Phase 2
Phase 2–3
Phase 3
Phase 4
No phase
Who can join
Healthy volunteers too
Searching
1–20 of 19,432
Completed
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
RATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a…
NCT00343382
·
Aurora, Colorado and 191 others
Active not recruiting
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
The purpose of this study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma or head…
NCT05913388
·
Portland, Oregon
Completed
Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
This Phase II trial evaluates the safety and immunogenicity of two doses of the Folate Receptor Alpha (FRα) peptide vaccine mixed with GM-CSF as a vaccine adjuvant, with or…
NCT02593227
·
Tampa, Florida and 10 others
Terminated
Early Rehabilitation for Breast Cancer - A Randomized Control Trial
Upper extremity strength, range of motion, activity limitations, fatigue and pain are well-documented concerns for women receiving treatment for breast cancer.
NCT04777786
·
Columbia, South Carolina
Completed
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 A: First-in-human phase 1 study to determine safety of NP-G2-044 when given orally on a daily X 28 days followed by a 14 day rest period.
NCT03199586
·
Scottsdale, Arizona and 2 others
Recruiting
Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression
This study is a prospective, observational clinical research aimed at establishing a multimodal database encompassing clinical information and gut microbiome data from a sample of…
NCT06938373
·
Changsha, Hunan
Recruiting
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
The goal of this study is to plan for a large scale evaluation of a program called Mindful After Cancer, or MAC.
NCT07055854
·
Corvallis, Oregon and 2 others
Active not recruiting
PALbociclib CoLlaborative Adjuvant Study
This is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib to standard adjuvant endocrine…
NCT02513394
·
Mobile, Alabama and 436 others
Unknown
Identification and Preservation of Arm Lymphatics
Controversy in axillary reverse mapping in axillary lymph node dissection (ALND) possibly results from incomplete recognition of the arm lymphatic system (ALS) and its compromise…
NCT04446494
·
Wuhan, Hubei
Unknown
Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
This is a phase II trial of regorafenib in patients with metastatic melanoma harboring c-Kit mutations and/or amplifications of c-Kit gene copy number.
NCT02501551
·
Seoul
Unknown
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
This is a multi-center, randomized, open-label, parallel group study designed to evaluate efficacy and safety of fulvestrant followed, at progression, by examestane and everolimus…
NCT02404051
·
Asti and 40 others
Unknown
Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis
Radiotherapy for head and neck cancer can cause severe mucositis (ulcers in the mouth) and pain.
NCT04671862
·
Ottawa, Ontario
Unknown
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
To see the impact of obesity on the efficacy of adjuvant endocrine therapy with aromatase inhibitors in postmenopausal patients with early breast cancer in terms of: i)…
NCT01758146
·
Chandigarh
Completed
Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
Tumors are heterogeneous with varying response to chemotherapeutic agents.
NCT00212069
·
Singapore
Recruiting
Mediterranean Diet and Inequality in Early Breast Cancer
Social determinants such as education, income, marital status, and social networks play a crucial role in cancer outcomes, including breast cancer.
NCT07007169
·
Sønderborg, Southern Denmark and 2 others
Completed
Study of AMG 650 in Adult Participants With Advanced Solid Tumors
To evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).
NCT04293094
·
Los Angeles, California and 21 others
Completed
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
The investigators hypothesize that the administration of pembrolizumab combined to metronomic cyclophosphamide may be an interesting therapeutic option for female patients breast…
NCT03139851
·
Angers and 4 others
Withdrawn
BAriaTric Surgery After Breast Cancer Treatment (BATS)
This is a feasibility study to gain an understanding of the willingness of women with a history of early stage breast cancer and current obesity to enroll in a weight-loss study…
NCT03946423
Recruiting
SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
The goal of this clinical trial is to evaluate the efficacy and safety of SHR-A1811 plus pertuzumab in combination with or without albumin-paclitaxel neoadjuvant therapy for early…
NCT06927180
·
Zhengzhou, Henan
Terminated
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
The course of the disease in female patients with metastatic mammary carcinoma can vary greatly.
NCT00241046
Back
1
2
3
···
972
1 / 972
Next
Data from
ClinicalTrials.gov
Terms
